487 related articles for article (PubMed ID: 1689214)
21. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
Pinkus GS; Said JW
Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
[TBL] [Abstract][Full Text] [Related]
23. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
24. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
26. Cell surface antigens expressed by subsets of pre-B cells and B cells.
McKearn JP; Baum C; Davie JM
J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
28. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
29. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
Linder J; Ye Y; Armitage JO; Weisenburger DD
Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
[TBL] [Abstract][Full Text] [Related]
31. A novel human B-lymphocyte antigen shared with lymphoid dendritic cells: characterization by monoclonal antibody.
Ishii Y; Takami T; Kokai Y; Yuasa H; Fujimoto J; Takei T; Kikuchi K
Clin Exp Immunol; 1985 Sep; 61(3):624-32. PubMed ID: 3907905
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.
Pfreundschuh M; Mommertz E; Meissner M; Feller AC; Hassa R; Krueger GR; Diehl V
Anticancer Res; 1988; 8(2):217-24. PubMed ID: 3364933
[TBL] [Abstract][Full Text] [Related]
33. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
35. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
36. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
Gougos A; Letarte M
J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
[TBL] [Abstract][Full Text] [Related]
37. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
38. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
40. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
